Purchases and Sales Made in Q2 2024 in Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX) during Q2 2024. The information is specifically focused on institutions that hold shares of MoonLake Immunotherapeutics.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-79.6K- 81.7% |
$3.06M - $3.87M
|
17.8K
$767K
|
|
|
Aug 13, 2024
Q2 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-154K- 30.81% |
$5.92M - $7.48M
|
346K
$14.9M
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-160K- 69.88% |
$6.15M - $7.78M
|
69K
$2.97M
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-160K- 69.88% |
$6.15M - $7.78M
|
69K
$2.97M
|
|
|
Aug 14, 2024
Q2 2024
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-180K- 20.96% |
$6.91M - $8.74M
|
678K
$29.2M
|
|
|
Dec 03, 2024
Q2 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-351K- 85.77% |
$13.5M - $17.1M
|
58.2K
$2.5M
|
|
|
Aug 14, 2024
Q2 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-460K- 20.13% |
$17.7M - $22.4M
|
1.83M
$78.5M
|